Visura Announces Closing of Series B Financing
Funding will support company’s rapid, full commercialization of its TEECAD® System MINNEAPOLIS (January 18, 2022) —Visura Technologies,...
top of page
- Dec 5, 2022
Visura Proud Supporter of Mayo Clinic Echocardiography Conferences
TEECAD Innovation to be Showcased at Upcoming Mayo Clinic Continuing Education and American Society of Echocardiography (ASE) Meetings...
- Oct 5, 2022
Visura Named in MassDevice’s “10 Medical Start-ups You Should Know”
In a recent article in MassDevice’s Medical Design and Outsourcing publication, Visura was recognized as one of ten up-and-coming medical...
- Jun 7, 2022
Visura enables real-time visualization of TEE intubation with launch of TEECAD at ASE 2022
TEECAD Innovation Station offers attendees time with experts and technology MINNEAPOLIS, MN (June 7, 2022) —Visura Technologies, Inc., a...
- May 5, 2022
Visura to Attend ASE 2022
Visura Technologies will be attending the 33rd Annual American Society of Echocardiography (ASE) Scientific Sessions at the Seattle...
- Mar 22, 2022
Medical Device Industry Veteran Christine Horton Named Visura Chief Executive Officer
Horton joins the rapidly growing cardiology company to lead U.S. commercialization efforts
bottom of page